Cancer

FILE - In this Nov. 30, 2018 file photo, Associate Justice Ruth Bader Ginsburg, nominated by President Bill Clinton, sits with fellow Supreme Court justices for a group portrait at the Supreme Court Building in Washington. The Supreme Court says Ginsburg is missing arguments for the first time in more than 25 years as she recuperates from cancer surgery last month. (AP Photo/J. Scott Applewhite)
January 07, 2019 - 3:39 pm
WASHINGTON (AP) — Justice Ruth Bader Ginsburg is missing arguments for the first time in more than 25 years as she recuperates from cancer surgery last month, the Supreme Court said. Ginsburg was not on the bench as the court met Monday to hear arguments. It was not clear when she would return to...
Read More
FILE - This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. Eli Lilly is buying Loxo Oncology for about $8 billion as it continues to broaden its cancer treatment efforts. Loxo Oncology Inc. is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers. (AP Photo/Darron Cummings, File)
January 07, 2019 - 7:49 am
Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and thyroid...
Read More
FILE - In this file photo dated Saturday, Nov. 11, 2017, musician Johnny Clegg performs on stage during his own farewell concert in Johannesburg. The 65-year old Clegg who has survived pancreatic cancer for the last few years, says in an interview broadcast Tuesday Dec. 18, 2018, he has a greater awareness of mortality and enjoys feeding birds in his garden. (AP Photo/Denis Farrell, File)
December 19, 2018 - 9:23 am
JOHANNESBURG (AP) — South African musician Johnny Clegg says he is an "outlier" who has survived pancreatic cancer for the last few years, but he is preparing for hard times ahead. Clegg, whose multi-racial bands during white minority rule in South Africa attracted an international following, spoke...
Read More
December 17, 2018 - 6:17 pm
NEW YORK (1010 WINS) -- Solomon Haufano, 5, isn’t allowing his cancer diagnosis slow him down. The Seattle youngster has been dancing his way through treatment to a backdrop of Michael Jackson tracks. The video above captures his moves. Haufano was diagnosed with desmoplastic small round cell tumor...
Read More
The 2018 Nobel laureates in Physiology or Medicine Tasuko Honjo attends a press conference with James P. Allison at the Karolinska Institutet, Stockholm, Sweden, Thursday Dec. 6, 2018. (Janerik Henriksson/TT via AP)
December 06, 2018 - 9:44 am
STOCKHOLM (AP) — The winners of this year's Nobel Prize for Medicine say they expect substantial advances toward treating cancer in the next several decades although they say it's unlikely the disease could be eradicated. James Allison of the United States and Tasuku Honjo of Japan made the...
Read More
December 04, 2018 - 7:49 am
MIAMI (AP) — A worldwide search is on to find blood donors with a rare genetic variation to help save a 2-year-old South Florida girl battling cancer. Zainab Mughal has neuroblastoma and needs life-saving transfusions. But finding compatible donors is immensely challenging, because she's missing a...
Read More
FILE- In this July 24, 2013, file photo a security guard walks in front of the GlaxoSmithKline building in Shanghai, China. Shares of Tesaro soared early Monday, Dec. 3, 2018, after GlaxoSmithKline said it would pay about $5.1 billion in cash to buy the cancer drugmaker. (AP Photo/Eugene Hoshiko, File)
December 03, 2018 - 9:37 am
Shares of Tesaro soared Monday after GlaxoSmithKline said it would pay about $5.1 billion in cash to buy the cancer drugmaker. Glaxo plans to pay $75 per share for Tesaro, which makes the ovarian cancer treatment Zejula. That represents a premium of more than 60 percent to the stock's $46.38...
Read More
FILE - In this Oct. 10, 2018 file photo, plaintiff DeWayne Johnson, a school groundskeeper who says Roundup weed-killer caused his cancer, leaves a courtroom in San Francisco. Agribusiness giant Monsanto is appealing a $78 million verdict in favor of a dying California man who said the company's widely used Roundup weed killer was a major factor in his cancer. The company filed a notice of appeal Tuesday, Nov. 20, 2018, in San Francisco Superior Court challenging the August jury verdict in favor of Johnson. (AP Photo/Paul Elias, File)
November 20, 2018 - 8:20 pm
SAN FRANCISCO (AP) — Agribusiness giant Monsanto on Tuesday appealed a $78 million verdict in favor of a dying California man who said the company's widely used Roundup weed killer was a major factor in his cancer. The company filed a notice of appeal in San Francisco Superior Court challenging a...
Read More
Second lady of the United States Karen Pence speaks during an interview with the Associated Press at the residence of U.S ambassador to Japan in Tokyo, Tuesday, Nov. 13, 2018. (AP Photo/Koji Sasahara)
November 13, 2018 - 2:31 am
TOKYO (AP) — Karen Pence, the U.S. vice president's wife, announced Tuesday a $54,000 U.S. grant to a teacher at Tsukuba University in Japan for the study of art therapy, a little-known mental health profession she has championed under the Trump administration. Pence was in Japan while accompanying...
Read More
FILE - In this Thursday, Oct. 11, 2012 file photo, a pedestrian talking on a cellphone is silhouetted in front of a fountain in Philadelphia. Two U.S. government agencies are giving conflicting interpretations of a safety study on cellphone radiation: One says it causes cancer in rats. The other says there's no reason for people to worry. (AP Photo/Matt Rourke)
November 01, 2018 - 5:50 pm
WASHINGTON (AP) — Two U.S. government agencies are giving conflicting interpretations of a safety study on cellphone radiation: One says it causes cancer in rats. The other says there's no reason for people to worry. No new research was issued Thursday. Instead, the National Toxicology Program...
Read More

Pages